Literature DB >> 15590414

Sarcoglycan and integrin localization in normal human skeletal muscle: a confocal laser scanning microscope study.

G Anastasi1, G Cutroneo, G Rizzo, A Arco, G Santoro, P Bramanti, A G Vitetta, A Pisani, F Trimarchi, A Favaloro.   

Abstract

Many studies have been performed on the sarcoglycan sub-complex and a7B and b1D integrins, but their distribution and localization patterns along the non-junctional sarcolemma are still not clear. We have carried out an indirect immunofluorescence study on surgical biopsies of normal human skeletal muscle, performing double localization reactions with antibodies to sarcoglycans, integrins and sarcomeric actin. Our results indicate that the tested proteins colocalize with each other. In a few cases, a-sarcoglycan does not colocalize with the other sarcoglycans and integrins. We also demonstrated, by employing antibodies to all the tested proteins, that these proteins can be localized to regions of the sarcolemma corresponding either to the I-band or A-band. Our results seem to confirm the hypothesis of a correlation between the region of the sarcolemma occupied by costameric proteins and the metabolic type (fast or slow) of muscle fibers. On this basis, we suggest that slow fibers are characterized by localization of costameric proteins to I-bands, while fast fibers are characterized by localization of costameric proteins to A-bands. The results open a new line of research in understanding interactions between the components of the DGC and vinculin-talin-integrin complexes in the context of different fiber types. Moreover, the same results may be extended to skeletal muscle fibers affected by neuromuscular diseases to detect possible structural alterations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15590414

Source DB:  PubMed          Journal:  Eur J Histochem        ISSN: 1121-760X            Impact factor:   3.188


  5 in total

1.  CD82 Is a Marker for Prospective Isolation of Human Muscle Satellite Cells and Is Linked to Muscular Dystrophies.

Authors:  Matthew S Alexander; Anete Rozkalne; Alessandro Colletta; Janelle M Spinazzola; Samuel Johnson; Fedik Rahimov; Hui Meng; Michael W Lawlor; Elicia Estrella; Louis M Kunkel; Emanuela Gussoni
Journal:  Cell Stem Cell       Date:  2016-09-15       Impact factor: 24.633

2.  Identification of CAP as a costameric protein that interacts with filamin C.

Authors:  Mei Zhang; Jun Liu; Alan Cheng; Stephanie M Deyoung; Alan R Saltiel
Journal:  Mol Biol Cell       Date:  2007-09-26       Impact factor: 4.138

3.  Costameric proteins in human skeletal muscle during muscular inactivity.

Authors:  Giuseppe Anastasi; Giuseppina Cutroneo; Giuseppe Santoro; Alba Arco; Giuseppina Rizzo; Placido Bramanti; Carmen Rinaldi; Antonina Sidoti; Aldo Amato; Angelo Favaloro
Journal:  J Anat       Date:  2008-06-05       Impact factor: 2.610

4.  δ-Sarcoglycan-deficient muscular dystrophy: from discovery to therapeutic approaches.

Authors:  Alison M Blain; Volker W Straub
Journal:  Skelet Muscle       Date:  2011-03-17       Impact factor: 4.912

5.  Morphofunctional compensation of masseter muscles in unilateral posterior crossbite patients.

Authors:  G Cutroneo; G Vermiglio; A Centofanti; G Rizzo; M Runci; A Favaloro; M G Piancino; P Bracco; G Ramieri; F Bianchi; F Speciale; A Arco; F Trimarchi
Journal:  Eur J Histochem       Date:  2016-06-13       Impact factor: 3.188

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.